Global express delivery and logistics services provider DHL announced just before February that its DHL Express subsidiary rolled out a new offering geared towards shipping for clinical and pharmaceutical research, and medical device installation, between the US and Brazil.

Entitled DHL Medical Express Service (WMX), DHL stated that they launched this new service back in November  as a pilot program, and focuses on increased demand for faster and more reliable lead times, in response to regulatory steps that sometimes delay exports, noting that this service provides several major benefits for clinical trial patient, as temperature-sensitive biological products, as well as any needed medical device installation for any patient-specific treatments, exactly when needed.

DHL Express Americas CEO Mike Parra said in a statement that DHL Medical Express has, and will continue to provide for the needs of the clinical and pharmaceutical research industries with their developmental thinking, and intelligent processes. By launching the service in Brazil, he says, fulfils the company’s goal to bring their logistics offerings in Latin and South American countries, as they are the countries that have the highest volume of clinical trials being conducted.

According to Director of Life Sciences Healthcare Americas for DHL Express, Brian Bralynski, explained that the necessity of the service was due to the increased demand for faster and more predictable lead times of transports for the customers in the pharmaceutical and clinical research sectors.

He says that Medical Express Service manages the export and regulatory requirements for urgent shipments with specific temperature needs from several major cities in Brazil to most US destinations, all within 24-48 hours. Necessary documents are pre-prepared, which deals with the issue of exports being delayed due to existing regulatory complexities.

Bralynski explained that DHL didn’t handle these kinds of shipments due to the features of WMX, and its clinical trial platform had yet to be set up properly in Brazil.

DHL boasts that this move makes it logistics provider to set up a foothold in the Latin and South American markets with their own service, one that’s aimed at handling the needs of customers in the clinical research space. The company says that this represents a new alternative to the more traditional carriers that have operated in the region, and provides a good option for the region’s healthcare industry.